News Focus
News Focus
icon url

masterlongevity

09/11/10 1:08 PM

#103967 RE: DewDiligence #103942

i can imagine ofatumumab for RRMS is dead. THat's a tough market and they are far behind. i think they would need very good (tysabri or FTY like) efficacy to compete effectively